HomeCHRO • NYSEAMERICAN
Channel Therapeutics Corp
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.72M | -34.70% |
Net income | -1.93M | 52.30% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 513.44K | 432.67% |
Total assets | 1.37M | 1,320.41% |
Total liabilities | 4.08M | -37.57% |
Total equity | -2.71M | — |
Shares outstanding | 6.10M | — |
Price to book | -3.14 | — |
Return on assets | -260.05% | — |
Return on capital | -2,747.67% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -1.93M | 52.30% |
Cash from operations | -670.26K | -87.85% |
Cash from investing | — | — |
Cash from financing | -71.20K | -116.54% |
Net change in cash | -741.46K | -1,107.35% |
Free cash flow | 44.99K | 103.54% |
Previous close
$1.38
Day range
$1.31 - $1.41
Year range
$0.45 - $3.80
Market cap
8.00M USD
Avg Volume
14.39K
P/E ratio
-
Dividend yield
-
About
Founded
2002
Website
Employees
8
